539230 — Chemiesynth (Vapi) Income Statement
0.000.00%
- IN₹205.20m
- IN₹365.25m
- IN₹214.35m
Annual income statement for Chemiesynth (Vapi), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 209 | 164 | 189 | 214 |
| Cost of Revenue | ||||
| Gross Profit | 157 | 133 | 146 | 161 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 196 | 162 | 181 | 215 |
| Operating Profit | 13.9 | 2.37 | 7.78 | -0.728 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 8.14 | -4.51 | -0.082 | -10.5 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 5.55 | -3.88 | -1.06 | -9.89 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 5.55 | -3.88 | -1.06 | -9.89 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 5.55 | -3.88 | -1.06 | -9.89 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 1.8 | -1.26 | -0.35 | -3.22 |